MILTON Catelin has resigned from his role as chief executive officer of peak pharmaceutical group Medicines Australia (MA)after just 18 months in the leadership position (PD 24 Aug 16).
MA chairman Wes Cook said Catelin was moving back to the United Kingdom, having headed the organisation through a period of "significant transformation and growth for our sector.
"As an industry body we have benefited from his leadership of a highly experienced team who together have delivered meaningful health policy outcomes."
Catelin said he was leaving the organisation at a "time of great strength," with a Strategic Agreement and firm partnerships with the government.
"I am privileged to have been able to contribute to this extraordinary sector," he said.
A sub-committee of the Medicines Australia board will now commence a recruitment process for a new ceo for the organisation.
Catelin joined Medicines Australia after an eight month vacancy following the departure of former ceo Tim James (PD 21 Dec 15).
His own resignation has been rumoured for some months, with some reports suggesting a pending departure by Catelin since as early as July last year.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Mar 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Mar 18
